GBS Inc. (NYSE:GBS – Get Free Report)’s share price fell 3.1% during trading on Monday . The company traded as low as $2.41 and last traded at $2.48. 59,538 shares changed hands during trading, a decline of 94% from the average session volume of 955,325 shares. The stock had previously closed at $2.56.
GBS Trading Down 3.1 %
The firm has a 50-day moving average of $3.85 and a two-hundred day moving average of $2.07. The firm has a market capitalization of $36.93 million, a P/E ratio of -4.43 and a beta of 1.32.
About GBS
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Recommended Stories
- Five stocks we like better than GBS
- 5 Top Rated Dividend Stocks to Consider
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Value Stocks You Can Buy Before They Become Big
- Why Invest in 5G Stocks
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
